Initial Treatment for Acute Necrotizing Encephalitis of Childhood (ANEC) versus Acute Disseminated Encephalomyelitis (ADEM)
For ADEM, high-dose intravenous corticosteroids (methylprednisolone, 1 g intravenously daily for 3-5 days) are the first-line treatment, while ANEC requires a more aggressive approach with early combination therapy including corticosteroids, IVIG, and potentially IL-6 receptor blockade with tocilizumab within the first 24 hours.
Acute Disseminated Encephalomyelitis (ADEM) Treatment
First-Line Treatment
- High-dose intravenous corticosteroids:
Second-Line Treatments (if poor response to corticosteroids)
Plasma exchange (PLEX):
Intravenous immunoglobulin (IVIG):
Combination Therapy
- Consider starting with combination therapy (steroids + IVIG or steroids + PLEX) for severe presentations 1
Acute Necrotizing Encephalitis of Childhood (ANEC) Treatment
First-Line Treatment (Aggressive Approach)
- Early combination immunotherapy within first 24 hours 2:
- High-dose corticosteroids (methylprednisolone or dexamethasone)
- IVIG (2 g/kg divided over 5 days)
- IL-6 receptor blockade with tocilizumab - critical for improved outcomes 2
Timing Considerations
- Evidence suggests that administration of tocilizumab within the first 24 hours significantly improves long-term outcomes compared to delayed administration 2
- Early aggressive immunotherapy is essential due to the rapid progression and high mortality rate of ANEC 3
Key Differences in Management
Diagnostic Workup for Both Conditions
- Neuroimaging: MRI with contrast of brain, cervical, and thoracic spine 1, 4
- Lumbar puncture: CSF analysis including autoimmune encephalitis panel, oligoclonal bands, and viral PCRs 1, 4
- EEG: To evaluate for subclinical seizures 1, 4
- Serum studies: To rule out other conditions 1, 4
Critical Distinctions
- ADEM: Primarily responds to corticosteroids alone; additional therapies added sequentially if needed 1, 5
- ANEC: Requires immediate aggressive combination therapy including IL-6 blockade; sequential approach associated with poorer outcomes 2, 3
- Mortality risk: ANEC has significantly higher mortality (estimated 30%) compared to ADEM (estimated 10%) 6
ICU Considerations
- Both conditions may require ICU admission for:
Important Caveats and Pitfalls
Do not delay immunotherapy while awaiting complete diagnostic workup in suspected ANEC due to its rapid progression and high mortality 2, 3
Rule out infectious causes before starting immunotherapy, but empiric antimicrobial coverage may be needed while awaiting results 1, 4, 7
Monitor for treatment complications:
- Steroid-induced hyperglycemia, hypertension, and psychiatric effects
- IVIG-related thrombotic events
- PLEX-related bleeding risk and hemodynamic instability 1
Consider transfer to a specialized center with neurological expertise if diagnosis is uncertain or if the patient fails to improve with initial therapy 4
Avoid misdiagnosis: ANEC can be mistaken for viral encephalitis; consider both diagnoses in the appropriate clinical context 7, 6